{"nct_id":"NCT00868413","title":"Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia","status":"COMPLETED","status_verified_date":"2013-05","start_date":"2009-11","start_date_type":null,"primary_completion_date":"2013-05","primary_completion_date_type":"ACTUAL","completion_date":"2013-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}